Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Toxin A-predominant Pathogenic C. difficile: A Novel Clinical Phenotype.

Lin Q, Pollock NR, Banz A, Lantz A, Xu H, Gu L, Gerding DN, Garey KW, Gonzales-Luna AJ, Zhao M, Song L, Duffy DC, Kelly CP, Chen X.

Clin Infect Dis. 2019 Aug 11. pii: ciz727. doi: 10.1093/cid/ciz727. [Epub ahead of print]

PMID:
31400280
2.

Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.

Kelly CP, Chen X, Williams D, Xu H, Cuddemi CA, Daugherty K, Barrett C, Miller M, Foussadier A, Lantz A, Banz A, Pollock NR.

Clin Infect Dis. 2019 Apr 26. pii: ciz330. doi: 10.1093/cid/ciz330. [Epub ahead of print]

PMID:
31211839
3.

Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.

Banz A, Lantz A, Riou B, Foussadier A, Miller M, Davies K, Wilcox M.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00452-18. doi: 10.1128/JCM.00452-18. Print 2018 Aug.

4.

Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.

Pollock NR, Banz A, Chen X, Williams D, Xu H, Cuddemi CA, Cui AX, Perrotta M, Alhassan E, Riou B, Lantz A, Miller MA, Kelly CP.

Clin Infect Dis. 2019 Jan 1;68(1):78-86. doi: 10.1093/cid/ciy415.

5.

Red blood cells as innovative antigen carrier to induce specific immune tolerance.

Cremel M, Guérin N, Horand F, Banz A, Godfrin Y.

Int J Pharm. 2013 Feb 25;443(1-2):39-49. doi: 10.1016/j.ijpharm.2012.12.044. Epub 2013 Jan 7.

PMID:
23305866
6.

Tumor growth control using red blood cells as the antigen delivery system and poly(I:C).

Banz A, Cremel M, Mouvant A, Guerin N, Horand F, Godfrin Y.

J Immunother. 2012 Jun;35(5):409-17. doi: 10.1097/CJI.0b013e3182594352.

PMID:
22576346
7.

International seminar on the red blood cells as vehicles for drugs.

Godfrin Y, Horand F, Franco R, Dufour E, Kosenko E, Bax BE, Banz A, Skorokhod OA, Lanao JM, Vitvitsky V, Sinauridze E, Bourgeaux V, Gunter KC.

Expert Opin Biol Ther. 2012 Jan;12(1):127-33. doi: 10.1517/14712598.2012.631909. Epub 2011 Oct 25. No abstract available.

8.

Peritoneopericardial diaphragmatic hernia: a retrospective study of 31 cats and eight dogs.

Banz AC, Gottfried SD.

J Am Anim Hosp Assoc. 2010 Nov-Dec;46(6):398-404.

PMID:
21041332
9.

In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy.

Banz A, Cremel M, Rembert A, Godfrin Y.

Vaccine. 2010 Apr 9;28(17):2965-72. doi: 10.1016/j.vaccine.2010.02.013. Epub 2010 Feb 24.

PMID:
20188177
10.

Molecular regulation of Th2 immunity by dendritic cells.

Grunig G, Banz A, de Waal Malefyt R.

Pharmacol Ther. 2005 Apr;106(1):75-96. Epub 2004 Dec 20. Review.

PMID:
15781123
11.

Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo.

Martin B, Banz A, Bienvenu B, Cordier C, Dautigny N, Bécourt C, Lucas B.

J Immunol. 2004 Mar 15;172(6):3391-8.

12.

A unique subpopulation of CD4+ regulatory T cells controls wasting disease, IL-10 secretion and T cell homeostasis.

Banz A, Peixoto A, Pontoux C, Cordier C, Rocha B, Papiernik M.

Eur J Immunol. 2003 Sep;33(9):2419-28.

14.
15.

Natural regulatory CD4 T cells expressing CD25.

Papiernik M, Banz A.

Microbes Infect. 2001 Sep;3(11):937-45. Review.

PMID:
11564442
16.

[Controls by practitioners of pathological results from a detection drive for kidney disease].

Banz AK, Dubach UC, Ehrensperger T.

Schweiz Rundsch Med Prax. 1975 Mar 11;64(10):290-4. German. No abstract available.

PMID:
1215270

Supplemental Content

Support Center